Soujanya Sodavarapu, MD
Rheumatology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sodavarapu’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Illinois 125060184Temporary Medical Permit · since 2011 · expires 2014-06-30Specialty on the licence: Internal MedicineCancelledNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$14,526
Medicare paid this office $14,526 for 45 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 37 | $8,121 | $219 |
| Return visit (30+ min) | 17 | $2,916 | $133 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 19 | $544 | $16 |
Who their Medicare patients are
45 Original Medicare patients in 2024. Average age 73 · Women 58% · Health risk score 1.18. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 71% · Chronic kidney disease 31% · Diabetes 27% · Coronary heart disease 24%.
The office billed $55,034, Medicare allowed $18,120 and paid $14,526; for 201 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 45 | 201 | 73 | 1.18 | $55,034 | $14,526 |
| 2018 | 15 | 16 | 67 | 2.46 | $5,493 | $508 |
| 2014 | 12 | 14 | 63 | 0.92 | $1,762 | $745 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$85,124 in 2022
Medicaid paid $85,124 for 2,084 billed services this clinician did in 2022, up to 255 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,044 | $82,711 |
| Short return visit (20+ min) | 962 | $2,117 |
| Return visit (30+ min) | 59 | $193 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 19 | $103 |
| 2022 | 2,084 | 4 | 255 | $85,124 |
| 2021 | 6,676 | 6 | 303 | $284,784 |
| 2020 | 6,355 | 7 | 355 | $392,957 |
| 2019 | 4,295 | 8 | 206 | $249,956 |
| 2018 | 4,497 | 10 | 211 | $264,309 |
See the largest Medicaid services in earlier years
2021
| Clinic visit/encounter, all-inclusive | 3,473 | $276,313 |
| Short return visit (20+ min) | 2,895 | $6,824 |
| Return visit (30+ min) | 198 | $637 |
| New patient visit (30+ min) | 46 | $439 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $286 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 50 | $285 |
2020
| Clinic visit/encounter, all-inclusive | 3,359 | $383,330 |
| Short return visit (20+ min) | 2,577 | $8,192 |
| New patient visit (30+ min) | 37 | $498 |
| Return visit (30+ min) | 221 | $470 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $242 |
| Short return visit | 132 | $176 |
| OFF/OP EST MAY X REQ PHY/QHP | 17 | $49 |
2019
| Clinic visit/encounter, all-inclusive | 2,141 | $243,374 |
| Short return visit (20+ min) | 1,426 | $3,323 |
| Return visit (30+ min) | 251 | $1,226 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 31 | $682 |
| VITAL SIGNS RECORDED | 68 | $544 |
| Short return visit | 277 | $474 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 38 | $333 |
| Medication list documented in medical record (COA) | 63 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 2,211 | $250,481 |
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 89 | $4,527 |
| Short return visit (20+ min) | 1,391 | $2,403 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 113 | $2,287 |
| PPSV23 VACC 2 YRS+ SUBQ/IM | 16 | $1,143 |
| Return visit (30+ min) | 311 | $1,016 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 30 | $987 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 121 | $972 |
| Short return visit | 202 | $461 |
| Glucose; blood, reagent strip | 13 | $33 |
Drugs they prescribed that Part D paid
$312,568
Pharmacies billed $312,568 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 193) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
143 generic and fewer than 11 brand-name prescriptions · $312,568 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 11 | $144,961 | $13,178 |
| Methotrexate | 20 | $1,045 | $52 |
| Hydroxychloroquine Sulfate | 12 | $487 | $41 |
| Prednisone | 25 | $144 | $6 |
| Folic Acid | 11 | $37 | $3 |
Year by year
| 2024 | 193 | 54 | 0% (0) | None | $312,568 |
| 2023 | 228 | 58 | 0% (0) | None | $216,509 |
| 2022 | 3,024 | 305 | 1% (14) | 14% | $312,704 |
| 2021 | 5,410 | 389 | 2% (89) | 14% | $440,434 |
| 2020 | 4,536 | 375 | 2% (97) | 15% | $390,906 |
| 2019 | 3,800 | 270 | 3% (114) | 17% | $351,098 |
| 2018 | 4,223 | 328 | 3% (142) | 16% | $301,236 |
| 2017 | 4,187 | 319 | 4% (173) | 16% | $219,579 |
| 2016 | 3,260 | 239 | 5% (150) | 17% | $156,142 |
| 2015 | 1,473 | 180 | 6% (89) | None | $46,502 |
| 2014 | 138 | 61 | 12% (17) | None | $3,813 |
| 2013 | 26 | 18 | None | None | $982 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Actemra | 12 | $61,595 | $5,133 |
| Alendronate | 14 | $363 | $26 |
| Atorvastatin | 15 | $285 | $19 |
| Amlodipine Besylate | 11 | $176 | $16 |
| Omeprazole | 12 | $135 | $11 |
| Hydrochlorothiazide | 12 | $92 | $8 |
2022: 56 drugs
| Eliquis | 39 | $30,081 | $771 |
| Janumet | 15 | $19,946 | $1,330 |
| Januvia | 23 | $18,445 | $802 |
| Jardiance | 22 | $15,923 | $724 |
| Spiriva Handihaler | 16 | $13,567 | $848 |
| Jentadueto | 17 | $13,362 | $786 |
| Lantus Solostar | 23 | $12,222 | $531 |
| Symbicort | 17 | $8,688 | $511 |
| Novolog Flexpen | 14 | $8,602 | $614 |
| Levemir Flextouch | 11 | $7,382 | $671 |
| Basaglar Kwikpen U-100 | 23 | $7,331 | $319 |
| Lantus | 16 | $5,469 | $342 |
| Atorvastatin | 331 | $4,341 | $13 |
| Nano 2nd Gen Pen Needle | 40 | $2,775 | $69 |
| Albuterol Sulfate Hfa | 32 | $2,674 | $84 |
| Ezetimibe | 17 | $1,920 | $113 |
| Tamsulosin | 83 | $1,873 | $23 |
| Losartan | 169 | $1,758 | $10 |
| Rosuvastatin | 15 | $1,692 | $113 |
| Gabapentin | 122 | $1,665 | $14 |
| Metoprolol | 66 | $1,580 | $24 |
| Lisinopril | 140 | $1,383 | $10 |
| Amlodipine Besylate | 184 | $1,293 | $7 |
| Diclofenac | 23 | $1,189 | $52 |
| Levothyroxine | 65 | $1,129 | $17 |
| Omeprazole | 68 | $877 | $13 |
| Montelukast | 20 | $814 | $41 |
| Pantoprazole | 50 | $788 | $16 |
| Ventolin Hfa | 13 | $755 | $58 |
| Sure Comfort Pen Needle | 12 | $748 | $62 |
| Nifedipine Er | 23 | $715 | $31 |
| Metformin | 83 | $654 | $8 |
| Pregabalin | 13 | $652 | $50 |
| Hydrochlorothiazide | 132 | $649 | $5 |
| Famotidine | 59 | $614 | $10 |
| Metoprolol | 48 | $552 | $11 |
| Glipizide Er | 13 | $520 | $40 |
| Hydralazine | 46 | $504 | $11 |
| Finasteride | 28 | $462 | $17 |
| Hydroxyzine | 22 | $421 | $19 |
| Clopidogrel | 24 | $416 | $17 |
| Pravastatin | 20 | $374 | $19 |
| Omega-3 Acid Ethyl Esters | 12 | $371 | $31 |
| Insulin | 12 | $363 | $30 |
| Trazodone | 29 | $313 | $11 |
| Buspirone | 19 | $312 | $16 |
| Glipizide | 42 | $311 | $7 |
| Simvastatin | 28 | $309 | $11 |
| Fludrocortisone Acetate | 13 | $290 | $22 |
| Benazepril | 29 | $281 | $10 |
| Furosemide | 35 | $261 | $7 |
| Fluticasone Propionate | 19 | $239 | $13 |
| Carvedilol | 16 | $205 | $13 |
| Sertraline | 29 | $152 | $5 |
| Allopurinol | 15 | $121 | $8 |
| Meclizine | 11 | $115 | $10 |
2021: 85 drugs
| Eliquis | 46 | $33,859 | $736 |
| Januvia | 38 | $33,023 | $869 |
| Lantus Solostar | 42 | $26,711 | $636 |
| Symbicort | 30 | $25,912 | $864 |
| Xarelto | 24 | $25,397 | $1,058 |
| Janumet | 20 | $24,935 | $1,247 |
| Janumet Xr | 22 | $20,219 | $919 |
| Jardiance | 28 | $16,276 | $581 |
| Spiriva | 13 | $13,486 | $1,037 |
| Basaglar Kwikpen U-100 | 37 | $12,219 | $330 |
| Novolog Flexpen | 17 | $10,551 | $621 |
| Insulin Lispro Kwikpen U-100 | 33 | $10,428 | $316 |
| Lantus | 29 | $8,629 | $298 |
| Atorvastatin | 588 | $8,318 | $14 |
| Advair Diskus | 13 | $7,038 | $541 |
| Atrovent Hfa | 14 | $6,234 | $445 |
| Gabapentin | 262 | $4,795 | $18 |
| Ventolin Hfa | 39 | $3,837 | $98 |
| Albuterol Sulfate Hfa | 63 | $3,447 | $55 |
| Losartan | 331 | $3,209 | $10 |
| Tamsulosin | 160 | $2,676 | $17 |
| Ezetimibe | 30 | $2,368 | $79 |
| Metoprolol | 146 | $2,351 | $16 |
| Nano 2nd Gen Pen Needle | 36 | $2,259 | $63 |
| Lisinopril | 274 | $2,092 | $8 |
| Amlodipine Besylate | 313 | $2,024 | $6 |
| Levothyroxine | 104 | $1,980 | $19 |
| Omeprazole | 121 | $1,613 | $13 |
| Alcohol Prep Pads | 14 | $1,593 | $114 |
| Ultra-Fine Nano Pen Needle | 22 | $1,559 | $71 |
| Pantoprazole | 81 | $1,465 | $18 |
| Fluticasone Propionate | 67 | $1,260 | $19 |
| Hydrocodone-Acetaminophen | 36 | $1,063 | $30 |
| Sucralfate | 11 | $1,027 | $93 |
| Pregabalin | 23 | $1,014 | $44 |
| Hydralazine | 92 | $995 | $11 |
| Rosuvastatin | 14 | $916 | $65 |
| Hydrochlorothiazide | 210 | $883 | $4 |
| Finasteride | 50 | $878 | $18 |
| Nifedipine Er | 70 | $872 | $12 |
| Oxybutynin Chloride | 17 | $829 | $49 |
| Triamcinolone Acetonide | 12 | $802 | $67 |
| Famotidine | 67 | $724 | $11 |
| Metformin | 138 | $721 | $5 |
| Chlorthalidone | 15 | $697 | $46 |
| Hydrocortisone | 11 | $617 | $56 |
| Montelukast | 34 | $554 | $16 |
| Trazodone | 45 | $553 | $12 |
| Pravastatin | 44 | $550 | $13 |
| Metoprolol | 68 | $530 | $8 |
| Lactulose | 16 | $526 | $33 |
| Carvedilol | 48 | $518 | $11 |
| Glipizide Er | 18 | $484 | $27 |
| Simvastatin | 64 | $446 | $7 |
| Oxycodone-Acetaminophen | 11 | $442 | $40 |
| Diclofenac | 12 | $406 | $34 |
| Clopidogrel | 39 | $401 | $10 |
| Furosemide | 80 | $395 | $5 |
| Allopurinol | 26 | $391 | $15 |
| Insulin | 17 | $320 | $19 |
| Venlafaxine Hcl Er | 11 | $320 | $29 |
| Nystop | 11 | $304 | $28 |
| Sertraline | 57 | $302 | $5 |
| Glipizide | 55 | $282 | $5 |
| Meclizine | 25 | $268 | $11 |
| Fludrocortisone Acetate | 15 | $264 | $18 |
| Buspirone | 20 | $229 | $11 |
| Benazepril | 55 | $229 | $4 |
| Potassium Chloride | 21 | $227 | $11 |
| Spironolactone | 25 | $204 | $8 |
| Fluoxetine | 17 | $202 | $12 |
| Cyclobenzaprine | 28 | $171 | $6 |
| Ondansetron | 12 | $168 | $14 |
| Baclofen | 11 | $160 | $15 |
| Escitalopram | 15 | $146 | $10 |
| Alendronate | 17 | $132 | $8 |
| Tramadol | 40 | $126 | $3 |
| Ibuprofen | 32 | $125 | $4 |
| Hydroxyzine | 21 | $125 | $6 |
| Zolpidem | 25 | $124 | $5 |
| Euthyrox | 15 | $120 | $8 |
| Metformin Hcl Er | 14 | $119 | $9 |
| Prednisone | 13 | $59 | $5 |
| Bupropion Hcl Sr | 11 | $58 | $5 |
| Meloxicam | 13 | $10 | $1 |
2020: 72 drugs
| Januvia | 36 | $39,402 | $1,095 |
| Symbicort | 42 | $36,090 | $859 |
| Xarelto | 32 | $32,897 | $1,028 |
| Lantus Solostar | 44 | $21,654 | $492 |
| Janumet | 18 | $20,611 | $1,145 |
| Spiriva | 13 | $16,233 | $1,249 |
| Basaglar Kwikpen U-100 | 40 | $14,588 | $365 |
| Jardiance | 18 | $13,040 | $724 |
| Novolog Flexpen | 18 | $10,261 | $570 |
| Lantus | 20 | $8,731 | $437 |
| Advair Diskus | 12 | $8,234 | $686 |
| Atorvastatin | 447 | $6,345 | $14 |
| Ventolin Hfa | 52 | $4,721 | $91 |
| Albuterol Sulfate Hfa | 48 | $3,140 | $65 |
| Gabapentin | 220 | $2,966 | $13 |
| Tamsulosin | 161 | $2,795 | $17 |
| Losartan | 254 | $2,697 | $11 |
| Ezetimibe | 19 | $1,783 | $94 |
| Ultra-Fine Nano Pen Needle | 32 | $1,726 | $54 |
| Levothyroxine | 62 | $1,708 | $28 |
| Metoprolol | 82 | $1,589 | $19 |
| Lisinopril | 204 | $1,520 | $7 |
| Amlodipine Besylate | 237 | $1,374 | $6 |
| Hydralazine | 75 | $1,311 | $17 |
| Midodrine | 31 | $1,243 | $40 |
| Fluticasone Propionate | 69 | $1,090 | $16 |
| Omeprazole | 92 | $958 | $10 |
| Hydrochlorothiazide | 181 | $883 | $5 |
| Nifedipine Er | 42 | $868 | $21 |
| Finasteride | 78 | $842 | $11 |
| Pantoprazole | 64 | $781 | $12 |
| Hydrocodone-Acetaminophen | 57 | $767 | $13 |
| Pregabalin | 13 | $684 | $53 |
| Metformin | 104 | $677 | $7 |
| Montelukast | 35 | $672 | $19 |
| Glipizide Er | 21 | $646 | $31 |
| Pravastatin | 29 | $632 | $22 |
| Levetiracetam | 18 | $515 | $29 |
| Simvastatin | 62 | $511 | $8 |
| Furosemide | 80 | $511 | $6 |
| Baclofen | 15 | $504 | $34 |
| Oxycodone-Acetaminophen | 12 | $496 | $41 |
| Oxybutynin Chloride Er | 20 | $492 | $25 |
| Chlorthalidone | 11 | $492 | $45 |
| Carvedilol | 50 | $475 | $9 |
| Metoprolol | 69 | $443 | $6 |
| Famotidine | 45 | $437 | $10 |
| Mercaptopurine | 13 | $379 | $29 |
| Clopidogrel | 45 | $347 | $8 |
| Glipizide | 44 | $345 | $8 |
| Hydroxyzine | 17 | $293 | $17 |
| Insulin | 11 | $292 | $27 |
| Allopurinol | 28 | $283 | $10 |
| Sertraline | 33 | $282 | $9 |
| Hydrocortisone | 15 | $275 | $18 |
| Potassium Chloride | 18 | $257 | $14 |
| Paroxetine | 21 | $229 | $11 |
| Trazodone | 27 | $214 | $8 |
| Nystop | 12 | $207 | $17 |
| Spironolactone | 21 | $189 | $9 |
| Propranolol | 21 | $187 | $9 |
| Escitalopram | 13 | $180 | $14 |
| Ondansetron | 14 | $169 | $12 |
| Rosuvastatin | 11 | $158 | $14 |
| Amitriptyline | 11 | $155 | $14 |
| Benazepril | 31 | $153 | $5 |
| Cyclobenzaprine | 15 | $137 | $9 |
| Tramadol | 23 | $102 | $4 |
| Prednisone | 19 | $90 | $5 |
| Ibuprofen | 19 | $86 | $5 |
| Zolpidem | 19 | $54 | $3 |
| Single Use Swab | 12 | $53 | $4 |
2019: 71 drugs
| Januvia | 39 | $39,448 | $1,011 |
| Janumet | 28 | $31,278 | $1,117 |
| Symbicort | 44 | $25,708 | $584 |
| Xarelto | 22 | $24,448 | $1,111 |
| Spiriva | 20 | $24,387 | $1,219 |
| Kombiglyze Xr | 11 | $13,124 | $1,193 |
| Novolog | 18 | $12,412 | $690 |
| Lantus | 20 | $11,055 | $553 |
| Lyrica | 20 | $9,882 | $494 |
| Basaglar Kwikpen U-100 | 28 | $9,343 | $334 |
| Humalog | 22 | $9,173 | $417 |
| Ventolin Hfa | 75 | $6,617 | $88 |
| Atorvastatin | 373 | $5,442 | $15 |
| Breo Ellipta | 14 | $4,963 | $354 |
| Lantus Solostar | 11 | $4,585 | $417 |
| Gabapentin | 177 | $3,679 | $21 |
| Levothyroxine | 92 | $1,996 | $22 |
| Tamsulosin | 113 | $1,797 | $16 |
| Metoprolol | 66 | $1,639 | $25 |
| Losartan | 179 | $1,579 | $9 |
| Easy Comfort Pen Needle | 14 | $1,184 | $85 |
| Amlodipine Besylate | 200 | $1,179 | $6 |
| Lisinopril | 151 | $1,148 | $8 |
| Omeprazole | 81 | $1,121 | $14 |
| Bupropion Hcl Sr | 11 | $1,023 | $93 |
| Ultra-Fine Nano Pen Needle | 19 | $1,018 | $54 |
| Hydrocodone-Acetaminophen | 61 | $982 | $16 |
| Montelukast | 38 | $928 | $24 |
| Metformin | 102 | $867 | $9 |
| Ranitidine | 79 | $865 | $11 |
| Finasteride | 80 | $779 | $10 |
| Pantoprazole | 51 | $732 | $14 |
| Glipizide Er | 14 | $685 | $49 |
| Hydrochlorothiazide | 140 | $658 | $5 |
| Esomeprazole Magnesium | 13 | $609 | $47 |
| Fluticasone Propionate | 35 | $566 | $16 |
| Hydralazine | 52 | $544 | $10 |
| Oxybutynin Chloride Er | 15 | $486 | $32 |
| Carvedilol | 53 | $475 | $9 |
| Pravastatin | 28 | $463 | $17 |
| Metoprolol | 68 | $427 | $6 |
| Glipizide | 65 | $411 | $6 |
| Oxycodone-Acetaminophen | 14 | $375 | $27 |
| Amitriptyline | 14 | $354 | $25 |
| Allopurinol | 39 | $343 | $9 |
| Simvastatin | 50 | $341 | $7 |
| Furosemide | 53 | $340 | $6 |
| Clopidogrel | 29 | $324 | $11 |
| Venlafaxine Hcl Er | 15 | $319 | $21 |
| Paroxetine | 17 | $276 | $16 |
| Hydroxyzine | 27 | $258 | $10 |
| Ondansetron | 15 | $230 | $15 |
| Trazodone | 17 | $227 | $13 |
| Levetiracetam | 11 | $223 | $20 |
| Nitroglycerin | 12 | $214 | $18 |
| Doxazosin Mesylate | 13 | $184 | $14 |
| Sertraline | 33 | $180 | $5 |
| Fludrocortisone Acetate | 12 | $176 | $15 |
| Potassium Chloride | 15 | $168 | $11 |
| Acetaminophen-Codeine | 11 | $132 | $12 |
| Lactulose | 12 | $129 | $11 |
| Quetiapine | 12 | $124 | $10 |
| Tramadol | 24 | $121 | $5 |
| Famotidine | 14 | $119 | $8 |
| Single Use Swab | 11 | $110 | $10 |
| Zolpidem | 11 | $109 | $10 |
| Cyclobenzaprine | 13 | $99 | $8 |
| Azithromycin | 12 | $84 | $7 |
| Prednisone | 12 | $78 | $6 |
| Metformin Hcl Er | 13 | $52 | $4 |
| Benazepril | 11 | $38 | $3 |
2018: 76 drugs
| Januvia | 48 | $41,640 | $867 |
| Symbicort | 47 | $23,540 | $501 |
| Xarelto | 30 | $17,858 | $595 |
| Spiriva | 18 | $15,871 | $882 |
| Janumet | 20 | $14,433 | $722 |
| Basaglar Kwikpen U-100 | 31 | $10,932 | $353 |
| Advair Diskus | 18 | $10,829 | $602 |
| Kombiglyze Xr | 12 | $9,630 | $802 |
| Janumet Xr | 13 | $9,377 | $721 |
| Humalog | 22 | $9,111 | $414 |
| Lantus | 19 | $8,250 | $434 |
| Ventolin Hfa | 91 | $6,672 | $73 |
| Lyrica | 14 | $6,362 | $454 |
| Novolog Mix 70-30 | 12 | $5,612 | $468 |
| Atorvastatin | 312 | $3,808 | $12 |
| Gabapentin | 197 | $3,657 | $19 |
| Colchicine | 20 | $3,629 | $181 |
| Lidocaine | 13 | $2,795 | $215 |
| Metoprolol | 114 | $2,385 | $21 |
| Levothyroxine | 101 | $1,971 | $20 |
| Hydrocodone-Acetaminophen | 86 | $1,809 | $21 |
| Esomeprazole Magnesium | 16 | $1,658 | $104 |
| Tamsulosin | 129 | $1,498 | $12 |
| Omeprazole | 153 | $1,495 | $10 |
| Isosorbide Dinitrate | 11 | $1,403 | $128 |
| Lisinopril | 206 | $1,259 | $6 |
| Amlodipine Besylate | 266 | $1,103 | $4 |
| Losartan | 156 | $1,089 | $7 |
| Amitriptyline | 27 | $1,059 | $39 |
| Oxybutynin Chloride | 26 | $988 | $38 |
| Metformin | 125 | $918 | $7 |
| Proair Hfa | 14 | $856 | $61 |
| Insulin | 24 | $584 | $24 |
| Pantoprazole | 54 | $582 | $11 |
| Hydrochlorothiazide | 141 | $569 | $4 |
| Ranitidine | 64 | $539 | $8 |
| Glipizide Er | 15 | $526 | $35 |
| Chlorthalidone | 16 | $525 | $33 |
| Fluticasone Propionate | 39 | $516 | $13 |
| Allopurinol | 45 | $495 | $11 |
| Hydrocortisone | 12 | $491 | $41 |
| Paroxetine | 29 | $489 | $17 |
| Pravastatin | 32 | $486 | $15 |
| Montelukast | 34 | $479 | $14 |
| Phenytoin Sodium Extended | 11 | $454 | $41 |
| Escitalopram | 25 | $431 | $17 |
| Metoprolol | 65 | $414 | $6 |
| Simvastatin | 76 | $409 | $5 |
| Potassium Chloride | 15 | $362 | $24 |
| Doxazosin Mesylate | 17 | $358 | $21 |
| Lactulose | 16 | $353 | $22 |
| Carvedilol | 45 | $351 | $8 |
| Finasteride | 66 | $349 | $5 |
| Clopidogrel | 32 | $333 | $10 |
| Oxycodone-Acetaminophen | 18 | $318 | $18 |
| Gemfibrozil | 23 | $313 | $14 |
| Venlafaxine Hcl Er | 16 | $312 | $19 |
| Cyclobenzaprine | 18 | $305 | $17 |
| Glipizide | 78 | $279 | $4 |
| Hydralazine | 16 | $267 | $17 |
| Hydroxyzine | 22 | $256 | $12 |
| Furosemide | 51 | $247 | $5 |
| Losartan-Hydrochlorothiazide | 21 | $214 | $10 |
| Meclizine | 15 | $202 | $13 |
| Zolpidem | 14 | $179 | $13 |
| Trazodone | 19 | $174 | $9 |
| Sertraline | 28 | $136 | $5 |
| Tramadol | 27 | $131 | $5 |
| Benazepril | 24 | $124 | $5 |
| Triamcinolone Acetonide | 14 | $122 | $9 |
| Azithromycin | 12 | $117 | $10 |
| Baclofen | 11 | $112 | $10 |
| Metformin Hcl Er | 15 | $105 | $7 |
| Ibuprofen | 18 | $99 | $6 |
| Donepezil | 17 | $49 | $3 |
| Lisinopril-Hydrochlorothiazide | 13 | $25 | $2 |
2017: 78 drugs
| Januvia | 51 | $23,737 | $465 |
| Lantus | 55 | $19,641 | $357 |
| Kombiglyze Xr | 31 | $11,662 | $376 |
| Symbicort | 24 | $10,269 | $428 |
| Xarelto | 23 | $9,587 | $417 |
| Advair Diskus | 21 | $9,337 | $445 |
| Spiriva | 23 | $8,483 | $369 |
| Lantus Solostar | 19 | $7,192 | $379 |
| Tradjenta | 13 | $4,959 | $381 |
| Lyrica | 12 | $4,877 | $406 |
| Nexium | 16 | $4,610 | $288 |
| Ezetimibe | 15 | $3,928 | $262 |
| Ventolin Hfa | 57 | $3,135 | $55 |
| Atorvastatin | 295 | $3,079 | $10 |
| Gabapentin | 187 | $2,626 | $14 |
| Metoprolol | 100 | $1,955 | $20 |
| Esomeprazole Magnesium | 14 | $1,836 | $131 |
| Hydrocodone-Acetaminophen | 95 | $1,782 | $19 |
| Levothyroxine | 92 | $1,598 | $17 |
| Proair Hfa | 28 | $1,582 | $57 |
| Isosorbide Dinitrate | 12 | $1,368 | $114 |
| Insulin | 53 | $1,223 | $23 |
| Tamsulosin | 78 | $1,129 | $14 |
| Oxybutynin Chloride | 32 | $1,023 | $32 |
| Amlodipine Besylate | 267 | $998 | $4 |
| Omeprazole | 132 | $859 | $7 |
| Amitriptyline | 19 | $808 | $43 |
| Losartan | 161 | $803 | $5 |
| Metformin | 156 | $772 | $5 |
| Lisinopril | 188 | $765 | $4 |
| Pantoprazole | 66 | $760 | $12 |
| Venlafaxine Hcl Er | 32 | $726 | $23 |
| Allopurinol | 48 | $692 | $14 |
| Simvastatin | 125 | $567 | $5 |
| Hydrochlorothiazide | 134 | $520 | $4 |
| Oxycodone-Acetaminophen | 11 | $514 | $47 |
| Ranitidine | 74 | $481 | $7 |
| Metoprolol | 69 | $476 | $7 |
| Doxazosin Mesylate | 18 | $421 | $23 |
| Baclofen | 26 | $395 | $15 |
| Chlorthalidone | 15 | $393 | $26 |
| Montelukast | 41 | $382 | $9 |
| Phenytoin Sodium Extended | 12 | $375 | $31 |
| Cyclobenzaprine | 29 | $351 | $12 |
| Fluticasone Propionate | 22 | $338 | $15 |
| Clopidogrel | 44 | $329 | $7 |
| Diltiazem 24hr Er | 18 | $324 | $18 |
| Potassium Chloride | 18 | $297 | $17 |
| Paroxetine | 26 | $286 | $11 |
| Glipizide | 76 | $278 | $4 |
| Gemfibrozil | 25 | $256 | $10 |
| Hydralazine | 30 | $249 | $8 |
| Calcitriol | 16 | $237 | $15 |
| Venlafaxine | 11 | $233 | $21 |
| Carvedilol | 60 | $228 | $4 |
| Furosemide | 54 | $227 | $4 |
| Acarbose | 11 | $227 | $21 |
| Escitalopram | 26 | $219 | $8 |
| Sertraline | 33 | $201 | $6 |
| Lactulose | 18 | $201 | $11 |
| Finasteride | 27 | $191 | $7 |
| Nystop | 21 | $188 | $9 |
| Levetiracetam | 13 | $187 | $14 |
| Zolpidem | 12 | $135 | $11 |
| Fluoxetine | 12 | $133 | $11 |
| Tramadol | 37 | $126 | $3 |
| Ibuprofen | 18 | $111 | $6 |
| Hydroxyzine | 11 | $110 | $10 |
| Acetaminophen-Codeine | 14 | $103 | $7 |
| Trazodone | 14 | $102 | $7 |
| Hydrocortisone | 13 | $102 | $8 |
| Losartan-Hydrochlorothiazide | 13 | $98 | $8 |
| Meclizine | 16 | $82 | $5 |
| Benazepril | 13 | $81 | $6 |
| Atenolol | 14 | $80 | $6 |
| Prednisone | 15 | $73 | $5 |
| Glimepiride | 17 | $66 | $4 |
| Citalopram Hbr | 15 | $53 | $4 |
2016: 71 drugs
| Advair Diskus | 33 | $12,135 | $368 |
| Januvia | 31 | $10,907 | $352 |
| Lantus | 26 | $10,616 | $408 |
| Nexium | 35 | $10,481 | $299 |
| Symbicort | 29 | $10,324 | $356 |
| Zetia | 22 | $6,642 | $302 |
| Spiriva | 16 | $5,392 | $337 |
| Xarelto | 14 | $5,012 | $358 |
| Lantus Solostar | 13 | $4,893 | $376 |
| Janumet | 15 | $4,790 | $319 |
| Kombiglyze Xr | 13 | $4,377 | $337 |
| Lidocaine | 13 | $3,808 | $293 |
| Humalog | 15 | $3,754 | $250 |
| Atorvastatin | 215 | $2,325 | $11 |
| Gabapentin | 119 | $2,229 | $19 |
| Colchicine | 12 | $2,028 | $169 |
| Hydrocodone-Acetaminophen | 76 | $1,939 | $26 |
| Venlafaxine Hcl Er | 32 | $1,728 | $54 |
| Ventolin Hfa | 30 | $1,607 | $54 |
| Proair Hfa | 24 | $1,447 | $60 |
| Metoprolol | 59 | $1,314 | $22 |
| Levothyroxine | 70 | $1,078 | $15 |
| Isosorbide Dinitrate | 11 | $1,055 | $96 |
| Omeprazole | 137 | $965 | $7 |
| Tamsulosin | 47 | $872 | $19 |
| Lisinopril | 184 | $866 | $5 |
| Amlodipine Besylate | 191 | $824 | $4 |
| Acarbose | 19 | $676 | $36 |
| Oxycodone-Acetaminophen | 12 | $576 | $48 |
| Bd Ultra-Fine Pen Needle | 14 | $567 | $40 |
| Allopurinol | 50 | $552 | $11 |
| Losartan | 148 | $547 | $4 |
| Simvastatin | 110 | $527 | $5 |
| Hydrochlorothiazide | 109 | $506 | $5 |
| Baclofen | 19 | $479 | $25 |
| Amitriptyline | 16 | $447 | $28 |
| Montelukast | 43 | $427 | $10 |
| Oxybutynin Chloride | 16 | $387 | $24 |
| Metformin | 90 | $380 | $4 |
| Ranitidine | 55 | $374 | $7 |
| Pantoprazole | 43 | $360 | $8 |
| Insulin | 11 | $317 | $29 |
| Potassium Chloride | 22 | $314 | $14 |
| Metoprolol | 37 | $306 | $8 |
| Fluoxetine | 31 | $292 | $9 |
| Gemfibrozil | 39 | $277 | $7 |
| Venlafaxine | 11 | $244 | $22 |
| Paroxetine | 23 | $189 | $8 |
| Doxazosin Mesylate | 11 | $185 | $17 |
| Clopidogrel | 31 | $185 | $6 |
| Hydralazine | 25 | $165 | $7 |
| Tramadol | 38 | $152 | $4 |
| Escitalopram | 13 | $146 | $11 |
| Hydroxyzine | 13 | $140 | $11 |
| Levetiracetam | 11 | $137 | $12 |
| Diltiazem 24hr Cd | 12 | $135 | $11 |
| Carvedilol | 34 | $132 | $4 |
| Furosemide | 40 | $128 | $3 |
| Naproxen | 20 | $124 | $6 |
| Trazodone | 23 | $121 | $5 |
| Quetiapine | 11 | $94 | $9 |
| Ibuprofen | 15 | $85 | $6 |
| Meclizine | 12 | $82 | $7 |
| Sertraline | 21 | $82 | $4 |
| Glipizide | 27 | $71 | $3 |
| Citalopram Hbr | 17 | $65 | $4 |
| Lovastatin | 11 | $61 | $6 |
| Azithromycin | 11 | $53 | $5 |
| Benazepril | 13 | $45 | $3 |
| Glimepiride | 15 | $42 | $3 |
| Atenolol | 18 | $33 | $2 |
2015: 33 drugs
| Lantus | 13 | $3,997 | $307 |
| Proair Hfa | 28 | $1,483 | $53 |
| Gabapentin | 67 | $1,201 | $18 |
| Hydrocodone-Acetaminophen | 53 | $928 | $18 |
| Atorvastatin | 76 | $900 | $12 |
| Metoprolol | 25 | $518 | $21 |
| Lisinopril | 85 | $509 | $6 |
| Levothyroxine | 34 | $484 | $14 |
| Amlodipine Besylate | 94 | $455 | $5 |
| Baclofen | 22 | $408 | $19 |
| Simvastatin | 48 | $399 | $8 |
| Oxybutynin Chloride | 14 | $366 | $26 |
| Omeprazole | 46 | $324 | $7 |
| Tamsulosin | 17 | $317 | $19 |
| Allopurinol | 31 | $302 | $10 |
| Ibuprofen | 30 | $252 | $8 |
| Ranitidine | 26 | $228 | $9 |
| Hydrochlorothiazide | 53 | $214 | $4 |
| Venlafaxine | 13 | $214 | $16 |
| Metoprolol | 25 | $206 | $8 |
| Gemfibrozil | 25 | $205 | $8 |
| Losartan | 51 | $202 | $4 |
| Pantoprazole | 16 | $194 | $12 |
| Naproxen | 27 | $189 | $7 |
| Paroxetine | 17 | $179 | $11 |
| Tramadol | 23 | $173 | $8 |
| Metformin | 41 | $145 | $4 |
| Glipizide | 16 | $78 | $5 |
| Azithromycin | 11 | $69 | $6 |
| Trazodone | 11 | $67 | $6 |
| Cyclobenzaprine | 14 | $63 | $5 |
| Carvedilol | 11 | $52 | $5 |
| Furosemide | 12 | $45 | $4 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 14 | $121 | $9 |
Money from drug and device companies
$647 in 2024
| 2024 | 3 | 7 | None | $647 |
| 2023 | 4 | 5 | None | $511 |
| 2022 | 3 | 3 | None | $290 |
| 2020 | 1 | 2 | None | $34 |
| 2019 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tavneos | $411 | 4 payments
|
| Janssen Biotech | Tremfya | $221 | 2 payments
|
| Abbvie | Humira | $15 | 1 payment
|
See all 7 published payments
| Amgen | Meals · 2024-06-26 | Tavneos | $62 |
| Amgen | Meals · 2024-06-20 | None | $117 |
| Abbvie | Meals · 2024-05-02 | Humira | $15 |
| Amgen | Meals · 2024-04-30 | Krystexxa | $115 |
| Janssen Biotech | Education · 2024-04-22 | Tremfya | $99 |
| Amgen | Meals · 2024-03-26 | Tavneos | $117 |
| Janssen Biotech | Meals · 2024-03-02 | Tremfya | $122 |
See earlier years (2023, 2022, 2020, 2019)
2023: $511
| AbbVie | Skyrizi | $196 | 2 payments
|
| GlaxoSmithKline | Benlysta | $115 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $101 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $100 | 1 payment
|
2022: $290
| Abbvie | Rinvoq | $117 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $106 | 1 payment
|
| Janssen Biotech | Tremfya | $67 | 1 payment
|
2020: $34
| Smith+Nephew | Santyl | $34 | 2 payments
|
2019: $19
| Takeda Pharmaceuticals U.S.A. | None | $19 | 1 payment
|
Professional record
- NPI
- 1831470129
- Licence
- IL 125060184, OK 39001Illinois 125060184: Cancelled
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Federal specialty code 207QB0002X (207QB0002X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-08-31
- NPI last updated
- 2024-08-05
- NPI record certified
- 2024-08-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 800 Stanton L Young Blvd, Oklahoma City, OK, 73104 · 530 Ne Glen Oak Ave, Peoria, IL, 61637